7Baggers
 generation bio earnings missed by $0.54, revenue fell short of estimates  Investing.com Philippines Fri, 07 Nov 2025 08:00:00 GMT
 Generation Bio Announces Third Quarter 2025 Financial Results  The Manila Times Wed, 05 Nov 2025 21:16:14 GMT
 Generation Bio's Q3 net loss narrows to $5.5 mln  TradingView Wed, 05 Nov 2025 08:00:00 GMT
 volume spikes in generation bio co. stock – what they mean  newser.com Mon, 03 Nov 2025 07:27:28 GMT
 Comparing Generation Bio (NASDAQ:GBIO) & Nuvation Bio (NYSE:NUVB)  Defense World Thu, 30 Oct 2025 07:00:00 GMT

Generation Bio Co
(NASDAQ:GBIO) 

GBIO stock logo

Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous sy...

Founded: 2016
CEO: Cameron Geoffrey McDonough  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends